Evan Alley, MD, PhD, discusses the role of chemotherapy in lung cancer, explaining the great advances in side effect management in recent years, innovations in infusion, recent additions to the armamentarium, chemoradiation, specific approaches to NSCLC, anti-angiogenesis therapy, and finally, rational combinations for the cancer immunity cycle.

Related Links:
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient